GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Merus Labs International Inc (NAS:MSLI) » Definitions » LT-Debt-to-Total-Asset

Merus Labs International (Merus Labs International) LT-Debt-to-Total-Asset : 0.27 (As of Mar. 2017)


View and export this data going back to 1996. Start your Free Trial

What is Merus Labs International LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Merus Labs International's long-term debt to total assests ratio for the quarter that ended in Mar. 2017 was 0.27.

Merus Labs International's long-term debt to total assets ratio declined from Mar. 2016 (0.33) to Mar. 2017 (0.27). It may suggest that Merus Labs International is progressively becoming less dependent on debt to grow their business.

Merus Labs International LT-Debt-to-Total-Asset Historical Data

The historical data trend for Merus Labs International's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Merus Labs International LT-Debt-to-Total-Asset Chart

Merus Labs International Annual Data
Trend Sep07 Sep08 Sep09 Sep10 Sep11 Sep12 Sep13 Sep14 Sep15 Sep16
LT-Debt-to-Total-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.24 0.34 0.32 0.18 0.29

Merus Labs International Quarterly Data
Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17
LT-Debt-to-Total-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.33 0.32 0.29 0.28 0.27

Merus Labs International LT-Debt-to-Total-Asset Calculation

Merus Labs International's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Sep. 2016 is calculated as

LT Debt to Total Assets (A: Sep. 2016 )=Long-Term Debt & Capital Lease Obligation (A: Sep. 2016 )/Total Assets (A: Sep. 2016 )
=83.151/286.379
=0.29

Merus Labs International's Long-Term Debt to Total Asset Ratio for the quarter that ended in Mar. 2017 is calculated as

LT Debt to Total Assets (Q: Mar. 2017 )=Long-Term Debt & Capital Lease Obligation (Q: Mar. 2017 )/Total Assets (Q: Mar. 2017 )
=70.013/261.132
=0.27

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Merus Labs International  (NAS:MSLI) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Merus Labs International LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Merus Labs International's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Merus Labs International (Merus Labs International) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Merus Labs International Inc (NAS:MSLI) » Definitions » LT-Debt-to-Total-Asset
Comparable Companies
TSE:4597 HROW CVSI TSX:ALEF RMTI XKRX:072020 TSE:4582 XKRX:206650 XCNQ:LHS BOM:524164 XCNQ:TER KAR:AGP OSL:PHO BOM:506690 XCNQ:BILZ HKSE:03737 XXII XKRX:191420 XSAT:HAMLET ROCO:4132
Traded in Other Exchanges
N/A
Address
Website
http://www.meruslabs.com
Merus Labs International Inc was incorporated on October 1, 2012 in British Columbia. The Company is a specialty pharmaceutical company. It acquires prescription medicines in various categories which include on patent but at maturity stage of product life cycle; branded generics; under promoted products; Niche market pharmaceuticals; and products with annual sales below critical threshold for large pharma. The Company competes with multinational pharmaceutical development corporations to small, single product companies that may limit their activities to a particular therapeutic area or region or territory.

Merus Labs International (Merus Labs International) Headlines

From GuruFocus

Slow Growth Ahead; Updates on Merus Labs International, Enghouse Systems, Athabasca Minerals

By Gordon Pape Gordon Pape • 10-05-2015

Merus Labs International: A Pharma Stock With Growth Potential

By Gordon Pape Gordon Pape • 03-30-2015

Update on Merus Labs International, Athabasca Minerals Inc, Enghouse Systems Limited, WiLAN Inc.

By Gordon Pape Gordon Pape • 06-22-2015